Objective• To explore the application value of combined detection of multiple tumor markers
in diagnosing lung cancer (LC). Methods• A total of 32 small cell lung cancer (SCLC) …

Tumor markers are beneficial for the diagnosis and therapy monitoring of lung cancer.
However, the value of tumor markers in lung cancer histological diagnosis is unknown. In …

To evaluate the predictive value of combined five tumor markers (TMs) CEA, NSE, SCCA,
CYFRA21-1 and ProGRP in the diagnosis of lung cancer (LC). Total of 305 hospitalized …

Serum tumor markers are non-invasive diagnostic tools for malignant tumor and commonly
used for screening of cancer and as an indicator of treatment-effect. In small cell lung …

3038 Background: A double-blind clinical study was conducted on 304 clinically verified
blood serum samples, including 141 non-small cell lung cancer (NSCLC), 133 healthy …

Background The trends in usage of tumor markers, including CEA, SCC, NSE, Cyfra21‐1,
and ProGRP, in Chinese lung cancer patients in the real‐world setting are not fully …

Objective To explore the values of combined detection of carcino embryonic antigen (CEA),
carcinoma antigen 125 (CA 125), cytokerain 19 fragment 21-1 (CYFRA2 1-1), carcinoma …

Background: To evaluate the value of six tumor markers including squamous cell carcinoma
antigen (SCCA), cytokeratin 19 fragment (CYFRA21-1), carcinoembryonic antigen (CEA) …

Background With the increasing prevalence of lung cancer, it has become imperative to
identify reliable biomarkers that can aid in early detection and prognosis assessment …

Objective To investigate the diagnostic value of combined detection of serum tumor markers,
including CEA, CA125, neuron-specific enolase (NSE) and cytokeratin fragment antigen 21 …